Tramadol

CHEMBL1237044 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
5-7 hours
Bioavailability
Protein Binding
Molecular Weight
263.4 g/mol
LogP
2.6
Phase
4

Acting through two mechanisms at once, tramadol both stimulates mu-opioid receptors and blocks the reuptake of serotonin and norepinephrine, combining a weak opioid effect with the monoamine action seen in some antidepressants. It is prescribed for moderate to moderately severe pain and is considered less potent than morphine. A small molecule (C16H25NO2) with a half-life of roughly 5 to 7 hours, its dual pharmacology brings distinctive risks: at higher doses or in combination with serotonergic medicines it can contribute to seizures and to serotonin excess, and like other opioids it can cause dependence and respiratory depression. These interactions make its use alongside antidepressants a particular concern. Tramadol is an approved analgesic occupying a middle ground between non-opioid pain relievers and stronger opioids.

This prescription pain reliever is used to treat moderate to moderately severe pain and works through a combination of opioid receptor binding and inhibition of serotonin and norepinephrine reuptake in the brain. It is considered a weaker opioid than morphine but still carries risks of dependence, respiratory depression, and seizures, especially at higher doses. It can interact dangerously with many other medications, including antidepressants.

น้ำหนักโมเลกุล

263.3750 g/mol

LogP

2.60

TPSA

32.70 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

หมวดหมู่ยา

กลไกการออกฤทธิ์

Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

Pharmacokinetics (PK)

Half-Life 5-7 hours

Pharmacodynamics (PD)

กลไก

Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cccc(C2(O)CCCCC2CN(C)C)c1

InChI

InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3

Molecular Formula

C16H25NO2

HBD / HBA

1 / 3

พันธะที่หมุนได้

4

อะตอมหนัก

19

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This prescription pain reliever is used to treat moderate to moderately severe pain and works through a combination of opioid receptor binding and inhibition of serotonin and norepinephrine reuptake in the brain. It is considered a weaker opioid than morphine but still carries risks of dependence, respiratory depression, and seizures, especially at higher doses. It can interact dangerously with many other medications, including antidepressants.

Mu-opioid receptor agonist and serotonin-norepinephrine reuptake inhibitor.

Key pharmacokinetic parameters for Tramadol: Half-life: 5-7 hours.

Yes, Tramadol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1237044. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 33741. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.